New pill aims to extend life for deadly brain cancer patients
Disease control
Not yet recruiting
This study is testing if adding a new oral medication called NG101m to the standard treatment helps people with newly diagnosed glioblastoma, a serious brain cancer, live longer. All participants will take NG101m capsules along with their usual chemotherapy and radiation. The mai…
Phase: PHASE1, PHASE2 • Sponsor: NeuGATE Theranostics • Aim: Disease control
Last updated Apr 02, 2026 02:26 UTC